News   | Nadmed Ltd | The standard of NAD measuring
  • Nadmed search
  • Home
  • Products
    • ALL PRODUCTS
    • Q40 NAD+ & NADH Blood Kit (CE)
    • Q16 NAD+ & NADH Small Blood Kit (CE)
    • Laboratory service
    • Q40 NAD+ & NADH Blood Kit (RUO)
    • Q16 NAD+ & NADH Small Blood Kit (RUO)
    • Q40 NAD+ & NADH Tissue / Cell Kit (RUO)
    • Q40 NADP+ & NADPH Blood Kit (RUO)
  • Science
  • Story
  • NADs
  • FAQ
  • News
  • Documents
  • People
  • Partners
  • Contact

News

 

Research Calls for Controlled Dosing of NAD-boosters

Research Calls for Controlled Dosing of NAD-boosters

A study involving a healthy population of 1162 individuals revealed that persistent high niacin...

read more
High NAD amounts slow growth of proliferative cancer cells

High NAD amounts slow growth of proliferative cancer cells

In a recent study, researchers found that high NAD(H)+ amounts slow down the growth of highly...

read more
Paving the Way in Parkinson’s Research

Paving the Way in Parkinson’s Research

Full NADMED REDOX profiling was used in a Norwegian study to contribute to Parkinson’s research....

read more
« Older Entries
Next Entries »

Contact us!

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Clear Signature
Consent*

NADMED Ltd.
Biomedicum 2U
Tukholmankatu 8
00290 Helsinki
FINLAND

OFFICE
+358 (0)10 375 1180
info@nadmed.com
LABORATORY
+358 (0)10 375 1181
laboratory@nadmed.com
IN COLLABORATION WITH
Collaboration between Upgraded and Nadmed
Collaborarion between Nadmed and Terkko Health Hub
Collaboration with Nadmed and Biotype
Collaboration between Upgraded and Nadmed
Collaborarion between Nadmed and Terkko Health Hub
Collaboration with Nadmed and Biotype
Collaboration between Upgraded and Nadmed
Collaborarion between Nadmed and Terkko Health Hub
Collaboration with Nadmed and Biotype

Copyright 2022 NADMED | Business ID: FI3259265–3 |  Privacy policy

Website: Amanda Visuals | HilMa Oy